B+
Bull case
20%
Probability
Target price
$6.00
Analysis reference price unavailable
Analysis 2026-01-09 · RankAlpha Sentiment AI
ORMP
OramedFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Bull case assumes positive clinical/regulatory outcomes and at least one commercial partnership that validates the oral-protein delivery platform and materially expands addressable market, justifying a significant multiple re-rate and >70% upside from the anchor. Reviewer note: recent aggregator snippets show consensus targets near $3.25–3.32 (sanity check vs.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
Clinical trial failure or negative data
Momentum
13
Value
44
Sentiment
38
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.30 · Bull $6.00 · Bear $1.80Analysis 2026-01-09; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-09 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $7.00
Why
Momentum13 · Δ7d -
Value44 · Δ7d -0.1
Sentiment38 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.1.
Contradictions & invalidation
- • Clinical trial failure or negative data
- • Competitive advances in oral biologics delivery
- • Bear case assumes failed pivotal readouts or inability to commercialize the platform without dilutive financing, returning the equity toward prior lows and steep downside (~45–55%).
Catalyst clock
2026-04-09
Next quarterly/earnings update
Lead driver: Value · See fundamentals
Momentum
13
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
44
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.4
Sentiment
38
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 13.1 / Value 43.7 / Sentiment 38.1
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-01-09. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$3.30
Analysis reference price unavailable
Analysis 2026-01-09 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$1.80
Analysis reference price unavailable
Analysis 2026-01-09 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$171.8M
Beta
1.33
Shares Out
41.6M
P/E (TTM)
2.9
P/S (TTM)
58.91
P/FCF (TTM) · Derived
-29.86
Rev YoY
-100.0%
EPS YoY
+489.6%
Gross Margin
-5.4%
Op Margin
-650.5%
Net Debt
-$125.07M
Current Ratio
4.98
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data